1. Glucagon-like peptide-1 7-36: a physiological incretin in man;Kreymann;Lancet,1987
2. Discovery, characterization, and clinical development of the glucagon-like peptides;Drucker;J. Clin. Invest.,2017
3. Glucagon-like peptide 1 (GLP-1);Müller;Mol. Metab.,2019
4. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers;Nauck;J. Clin. Endocrinol. Metab.,2002
5. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans;Nauck;Am. J. Physiol.,1997